The Board of Directors take pleasure in presenting the Twenty-Seventh (27th) Annual Report including inter-alia
Directors' Report, its annexures and audited financial statements (including standalone and consolidated
financial statements along with respective Auditors' Report thereon) for the year ended 31st March, 2025. The
consolidated performance of the Company and its subsidiaries has been referred to wherever required. The
Companies Act, 2013 and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are
referred to as ‘Act' and ‘Listing Regulations' respectively.

1. FINANCIAL SUMMARY/HIGHLIGHTS:

The performance of the Company for the period ended 31st March, 2025 is as under:

(Rs. In Lakhs)

2. OVERVIEW & STATE OF THE COMPANY’SAFFAIRS:

Revenues-standalone

During the year under review, the Company on a standalone basis has recorded an income of Rs. 4423.90
Lakhs and profit of Rs. 72.20 Lakhs as against the income of Rs. 3919.17 Lakhs and loss of Rs. 102.87
Lakhs respectively in the previousfinancial year ending 31.03.2024.

Revenues - Consolidated

During the year under review, the Company on a consolidated basis has recorded an income of Rs.

4749.62 Lakhs and profit of Rs. 4.53 Lakhs as against the income of Rs. 4032.51 Lakhs and loss of Rs.

130.62 Lakhs respectively in the previousfinancial year ending 31.03.2024.

3. DIVIDEND:

No dividend is proposed for the year under review.

4. TRANSFER TO RESERVES:

Pursuant to provisions of Section 134 (3) (j) of the Companies Act, 2013, the Company has not transferred
any amount to general reserves account of the Company during the year under review.

5. MATERIAL CHANGES & COMMITMENTAFFECTING THE FINANCIAL POSITION OF THE COMPANY:

There have been no material changes and commitments affecting the financial position of the Company
which have occurred between the end of the Financial Year of the Company to which the financial
statements relate and the date of the report.

6. SIGNIFICANT & MATERIAL ORDERS PASSED BY THE REGULATORS OR COURTS OR
TRIBUNALS:

No significant or material orders have been passed against the Company by the Regulators, Courts or
Tribunals, which impacts the going concern status and Company's operations in future.

7. REVISION OF FINANCIAL STATEMENTS:

There was no revision of the financial statements for the year under review.

8. CHANGE IN THE NATURE OF BUSINESS, IFANY:

The Company has not undergone any change in the nature of business during the FY2024-25.

9. DEPOSITSFROMPUBLIC:

The Company has not accepted any public deposits during the Financial Year ended March 31,2025 and
as such, no amount of principal or interest on public deposits was outstanding as on the date of the balance
sheet and hence there has been no non- compliance with the requirements of theAct.

10. INFORMATION ABOUT THE FINANCIAL PERFORMANCE / FINANCIAL POSITION OF THE
SUBSIDIARIES/ASSOCIATES:

The Company has one subsidiary namely Nayas Laboratories Private Limited situated in Hyderabad,
Telangana. In accordance with Section 129(3) of the Companies Act, 2013, a statement containing salient
features of the financial statements of the subsidiary company in FormAOC-1 is attached herewith forming
part of the Annual Report. In accordance with the proviso to Section 136(1) of the Companies Act, 2013, the
Annual Report of your Company, containing therein its audited standalone and the consolidated financial
statements has been placed on the website of the Company atwww.jeevanscientific.com.

11. COMPANIES WHICH HAVE BECOME OR CEASED TO BE SUBSIDIARIES:

During the financial year, no company have become or ceased to be subsidiary of the company.

12. INDEPENDENT DIRECTOR’S FAMILIARIZATION PROGRAMMES:

Independent Directors are familiarized about the Company's operations, businesses, financial
performance and significant development so as to enable them to take well-informed decisions in timely
manner. Interaction with the Business heads and key executives of the Company is also facilitated.
Detailed presentations on important policies of the Company are also made to the directors. Direct
meetings with the Chairperson are further facilitated to familiarize the incumbent Director about the
Company/its businesses and the group practices.

The details of familiarization programme held in FY 2024-25 are also disclosed on the Company's website:
http://www.jeevanscientific.com.

13. BOARDEVALUATION

Performance of the Board and Board Committees was evaluated on various parameters such as structure,
composition, diversity, experience, corporate governance, competencies, performance of specific duties
and obligations, quality of decision-making and overall Board effectiveness. Performance of individual
Directors was evaluated on parameters such as meeting attendance, participation and contribution,
engagement with colleagues on the Board, responsibility towards stakeholders and independent
judgement.

All the Directors participated in the evaluation process conducted in February 2025. The Board discussed
the performance evaluation reports of the Board, Board Committees, Individual Directors. The Board upon
discussion noted the inputs of the Directors.

The detailed procedure followed for the performance evaluation of the Board, Committees and Individual
Directors is enumerated in the Corporate Governance Report.

14. MEETINGSOFTHEBOARD

The Board of Directors duly met 5 (Five) times on 30.05.2024, 09.08.2024, 08.11.2024, 06.02.2025 and
01.03.2025 in respect of which meetings, proper notices were given and the proceedings were properly
recorded and signed in the Minutes Book maintained for the purpose.

15. COMMITTEESOFTHEBOARD

There are various Board Committees as stipulated under the Act and Listing Regulations namely Audit
Committee, Nomination and Remuneration Committee, Stakeholders Relationship, Corporate Social
Responsibility Committee and Risk Management Committee. Brief details pertaining to composition, terms
of reference, meetings held and attendance thereat of these Committees during the year have been
enumerated in Corporate Governance Report forming part of thisAnnual Report.

16. AUDIT COMMITTEE RECOMMENDATIONS:

During the year, all recommendations ofAudit Committee were approved by the Board of Directors.

17. APPOINTMENT / RE-APPOINTMENT / RESIGNATION / RETIREMENT OF DIRECTORS /CEO/ CFO
AND KEY MANANGERIAL PERSONNEL

As on date of this report, the Company has nine Directors, out of which Four are Independent and four are
executive including one women director and two non-executive Directors.

a) Appointment/Re-appointment/Resignation of Directors/KMP of the Company

• Appointment of Mr. Krishna Sainadh Kodati as Company Secretary of the Company with effect from 30th
May, 2024.

• Resignation of Mrs. Snigdha Mothukuri as Chief Executive Officer of the Company with effect from 08th
November, 2024.

• Resignation of Mr. Jeevan Krishna Kuchipudi as Chief Financial Officer of the Company with effect from
08th November, 2024.

• Appointment of Dr. Srinivas Reddy Maram as Chief Executive Officer of the Company with effect from 08th
November, 2024.

• Change in designation of Mr. Jeevan Krishna Kuchipudifrom Executive Directorto Non- Executive Director
with effect from 08th November, 2024.

• Appointment of Mr. Venkateswara Rao Ravipati as Chief Financial officer of the Company with effect from
06th February, 2025.

b) Key Managerial Personnel:

Key Managerial Personnel forthefinancial year2024-25

• Mr. Kuchipudi Krishna Kishore, Managing Directorof the company.

• Mrs. Snigdha Mothukuri, Executive Directorof the company.

• Mr. Nageswar Rao Yarllagadda, Executive Directorof the company.

• Dr. Srinivas Reddy Maram, Chief Executive Officerof the Company

• Mr. Venkateswara Rao Ravipati, Chief Financial officerof the Company

• Mr. Krishna Sainadh Kodati as Company Secretary and Compliance Officer of the company.

c) Information u/r 36(3) of SEBI (LODR), Regulations, 2015:

As required under regulation 36 (3) of the SEBI (LODR), Regulations, 2015, brief particulars of the Directors
seeking appointment/re-appointments are given asAnnexureAtothe notice of the AGM forming part of this
Annual Report.

18. STATUTORYAUDITANDAUDITORS REPORT:

The members of the Company in accordance with Section 139 of the Companies Act, 2013 have passed a
resolution for appointment of M/s. Pavuluri & Co., Chartered Accountants, Hyderabad (Firm Registration
No. 012194S) as Statutory Auditors of the Company for a period of 5 years in the AGM held on 29.09.2022
to hold office up to the conclusion of 29th Annual General Meeting of the Company to be held for the
financial year 2026-2027.

The notes of the financial statements referred to in the Auditors' Report issued by M/s. Pavuluri & Co.,
Chartered Accountants, Hyderabad for the financial year ended on 31st March, 2025 are self-explanatory
and do not call for any further comments. The Auditors' Report does not contain any qualification,
reservation or adverse remark.

19. INTERNALAUDITORS:

Pursuant to provisions of Section 138 read with Rule 13 of the Companies (Accounts) Rules, 2014 and
Section 179 read with Rule 8(4) of the Companies (Meetings of Board and its Powers) Rules, 2014; during
the year under review, the Internal Audit of the functions and activities of the Company was undertaken by
M/s. K P &Associates the InternalAuditorof the Company.

Deviations are reviewed periodically and due compliance was ensured. Summary of Significant Audit
Observations along with recommendations and its implementations are reviewed by the Audit Committee
and concerns, if any, are reported to the Board. There were no adverse remarks or qualification on accounts
of the Companyfrom the InternalAuditor.

The internal audit is conducted at the Company and covered all key areas. All audit observations and follow
up actions are discussed with the Management as also the Statutory Auditors and the Audit Committee
reviews the same regularly.

The Board has re-appointed M/s. K P & Associates, Chartered Accountants, Hyderabad, as Internal
Auditors for the Financial Year2025-26.

20. SECRETARIALAUDITOR& AUDIT REPORT:

M/s. Aakanksha Dubey & Co., Practicing Company Secretaries were appointed as the Secretarial Auditors
of the Company for a period of 5 (five) consecutive years, commencing from Financial Years 2025-26 to
2029-30, at the Board meeting held on 30th May 2025, based on the recommendation of the Audit

Committee, subject to the approval of the Members at the ensuing AGM of the Company. They will
undertake secretarial audit as required and issue the necessary secretarial audit report for the aforesaid
period in accordance with the provisions of Section 204 of the Act and the Companies (Appointment and
Remuneration of Managerial Personnel) Rules, 2014 and amended Regulation 24a of the Listing
Regulations.

They have confirmed that their appointment complies with the eligibility criteria in terms of Listing
Regulations. The resolution seeking Members' approval for their appointment forms part of the Notice
under item no.4.

The Secretarial Audit Report confirms that the Company has complied with the provisions of theAct, Rules,
Regulations and Guidelines and that there were no deviations or non-compliances. The Secretarial Audit
Report is provided as Annexure-I to this Report. The Secretarial Audit Report does not contain any
qualifications, reservations or adverse remarks or disclaimers.

21. ANNUAL SECRETARIAL COMPLIANCE REPORT:

SEBI vide its Circular No. CIR/CFD/CMD1/27/2019 dated February 08,2019 read with Regulation 24(A) of
the Listing Regulations, directed listed entities to conduct Annual Secretarial compliance audit from a
Practicing Company Secretary of all applicable SEBI Regulations and circulars/guidelines issued
thereunder. Further, Secretarial Compliance Report dated May 30, 2025, was given by M/s. Aakanksha
Dubey & Co.,, Practicing Company Secretaries which was submitted to BSE Limited.

22. COSTRECORDSANDCOSTAUDIT:

Maintenance of cost records and requirement of cost audit as prescribed under the provisions of Section
148(1) of theAct, are not applicable for the business activities carried out by the Company.

23. NO FRAUDS REPORTED BYSTATUTORYAUDITORS:

During the Financial Year 2024-25, the Auditors have not reported any matter under section 143(12) of the
Companies Act, 2013, therefore no detail is required to be disclosed under section 134(3) (ca) of the
CompaniesAct, 2013.

24. DECLARATION FROM INDEPENDENT DIRECTORS ONANNUAL BASIS

The Company has, inter alia, received the following declarations from all the Independent Directors as
prescribed undersub-section (6)of Section 149 of the CompaniesAct, 2013and under Regulation 16(1)(b)
read with Regulation 25 of the SEBI (LODR), Regulations, 2015 confirming that:

a. they meet the criteria of independence as prescribed under the provisions of the Act, read with Schedule IV
and Rules issued thereunder, and the Listing Regulations. There has been no change in the circumstances
affecting theirstatus as Independent Directors of the Company;

b. they have complied with the Code for Independent Directors prescribed under Schedule IV to theAct; and

c. they have registered themselves with the Independent Director's Database maintained by the Indian
Institute of CorporateAffairs and have qualified the online proficiency self-assessment test or are exempted
from passing the test as required in terms of Section 150 of the Act read with Rule 6 of the Companies
(Appointment and Qualifications of Directors) Rules, 2014.

d. they had no pecuniary relationship or transactions with the Company, other than sitting fees, commission
and reimbursement of expenses incurred by them for the purpose of attending meetings of the Board of
Directors and Committee(s).

The Board of Directors of the Company has taken on record the declaration and confirmation submitted by
the Independent Directors after undertaking due assessment of the veracity of the same.

25. CONSERVATION OF ENERGY, TECHNOLOGYABSORPTIONAND FOREIGN EXCHANGE OUTGO:

The required information as per Sec.134 of the CompaniesAct 2013 is provided hereunder:

A. Conservation of Energy:

The Company's operations are not energy intensive. Adequate measures have been taken to conserve
energy wherever possible by using energy efficient computers and purchase of energy efficient equipment.

B. TechnologyAbsorption:

Research and Development (R&D): JSTL's Bioanalytical research laboratory is designed with state of the
art facility equipped with advanced analytical instrumentation having 2 processing labs and 4 LC-MS/MS
labs, currently accommodating 12 LCMS/MS instruments and one ELISA. JSTL offers a unique
combination of highly trained workforce enabled with well-equipped bio analytical Research and
Development (R&D) laboratory. There was considerable adoption of new and challenging techniques by
our expert scientists to utilize our instruments to the best possible extent in development of methods used
for assessment of some critical and complex molecules.

The Company promotes innovation and ambitious work culture across all levels; we strive to adopt and
upgrade to new technology as well as new techniques/processes wherever applicable and feasible to
improve and optimize our systems resulting in high Quality deliverables to our customers. We are
continuously driving towards automation/digitization, resulting in more paperless procedures, accurate
database management, easy workflow management, reduced turnaround times and considerable cost
reduction with strict adherence to regulatory compliance.

C. Foreign Exchange Earnings and Out Go:

The foreign exchange earned in terms of actual inflows during the year and the foreign exchange outgo
during the year in terms of actual outflow: Please refer notes to accounts attached to this report.

26. CORPORATEGOVERNANCE:

Your Company has taken adequate steps to ensure compliance with the provisions of Corporate
Governance as prescribed under the Listing Regulations. A separate section on Corporate Governance,
forming a part of this Report and the requisite certificate from the Company's Auditors confirming
compliance with the conditions of Corporate Governance is attached to the report on Corporate
Governance asAnnexure-II.

27. MANAGEMENTDISCUSSIONANDANALYSISREPORT:

Management discussion and analysis report for the year under review as stipulated under Regulation 34(2)
(e) read with schedule V, Part B of SEBI (Listing Obligations and Disclosure Requirements), Regulations
2015 with the stock exchange in India is annexed herewith asAnnexure-III to this report.

28. RISKMANAGEMENTPOLICY:

The Board of Directors had constituted Risk Management Committee to identify elements of risk in different
areas of operations and to develop policy for actions associated to mitigate the risks. The Committee is
responsible for reviewing the risk management plan and ensuring its effectiveness. The major risks
identified by the businesses and functions are systematically addressed through mitigating actions on a
continual basis.

29. ANNUALRETURN:

Pursuant to Sections 92 & 134(3) of the Act and Rule 12 of the Companies (Management and
Administration) Rules, 2014, theAnnual Return in Form MGT-7 is also available on the Company's website:
https://www.jeevanscientific.com.

30. AUTHORISEDAND PAID-UP CAPITAL OF THE COMPANY:

The authorized capital of the company stands at Rs. 21,00,00,000/-divided into 2,10,00,000 equity shares
of Rs.10/-each.

The paid-up Share capital of the Company stands at Rs.15,83,39,650/- divided into 1,58,33,965 equity
shares of Rs.10/- each.

During the financial year Company has allotted 3,53,750 Equity shares under JSTL-ESOP Scheme 2016.

31. DECLARATION FROM DIRECTORS

None of the Directors of the Company are disqualified from being appointed as Directors as specified under
Section 164(1) and 164(2) of the Act read with Rule 14(1) of the Companies (Appointment and
Qualifications of Directors) Rules, 2014 (including any statutory modification(s) and/or re-enactment(s)
thereof for the time being in force) or are debarred or disqualified by the Securities and Exchange Board of
India (“SEBI”), Ministry of CorporateAffairs (“MCA”) or any other such statutory authority.

All members of the Board and Senior Management have affirmed compliance with the Code of Conductfor
Board and Senior Management for the financial year 2024-25. The Company had sought the following
certificates from independent and reputed Practicing Company Secretaries confirming that:

a. none of the Director on the Board of the Company has been debarred or disqualified from being appointed
and/or continuing as Directors by the SEBI/MCAor any other such statutory authority.

b. independence of the Directors of the Company in terms of the provisions of the Act, read with Schedule IV
and Rules issued thereunder and the Listing Regulations.

32. DIRECTOR’S RESPONSIBILITY STATEMENT:

In pursuance of section 134 (5) of the CompaniesAct, 2013, the Directors hereby confirm that:

a) In the preparation of the annual accounts, the applicable accounting standards had been followed along
with proper explanation relating to material departures;

b) The Directors had selected such accounting policies and applied them consistently and made judgments
and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the
company at the end of the financial year and of the profit and loss of the company for that period;

c) The Directors had taken proper and sufficient care for the maintenance of adequate accounting records in
accordance with the provisions of this Act for safeguarding the assets of the company and for preventing
and detecting fraud and other irregularities;

d) The Directors had prepared the annual accounts on a going concern basis; and

e) The Directors had laid down internal financial controls to be followed by the company and that such internal
financial controls are adequate and were operating effectively.

f) The Directors had devised proper systems to ensure compliance with the provisions of all applicable laws
and that such systems were adequate and operating effectively.

33. VIGIL MECHANISM/WHISTLE BLOWER POLICY:

The Company has formulated a Vigil Mechanism / Whistle Blower Policy pursuant to Reg. 22 of SEBI
(Listing Obligations and Disclosure Requirements), Regulations 2015 and Section 177(10) of the
CompaniesAct 2013, enabling stakeholders to report any concern of unethical behaviour, suspected fraud
or violation.

The said policy inter-alia provides safeguard against victimization of the Whistle Blower. Stakeholders
including directors and employees have access to the Vice Chairman and Managing Director and
Chairperson of theAudit Committee.

During the year under review, no stakeholder was denied access to the Chairperson of the Audit
Committee.

The policy is available on the website of the Company atwww.jeevanscientific.com.

34. EMPLOYEESTOCKOPTIONSCHEME:

The Company adopted an Employee Stock Option (ESOP) scheme, namely “Employee Stock Option
Scheme 2016-” (“JSTL- ESOP Scheme 2016) which helps the Company to retain and attract right talent.
The Nomination and Remuneration Committee (NRC) administers the Company's ESOP scheme. There
were no changes in the ESOP scheme during the financial year under review. The scheme is in compliance
with the Securities and Exchange Board of India (Share-Based Employee Benefits and Sweat Equity)
Regulations, 2021.

Following are the details of the ESOPs as on 31.03.2025:

Disclosure in compliance with the Securities and Exchange Board of India (Share-Based Employee Benefits and
Sweat Equity) Regulations, 2021 are available on the company website of the company at website:
https://www.jeevanscientific.com.

Further, a certificate from Mrs. Aakanksha Sachin Dubey, Secretarial Auditor of the Company certifying that the
(“JSTL- ESOP Scheme 2016) has been implemented in accordance with these regulations and in accordance
with the resolution of the Company in the general meeting is enclosed asAnnexure-IV.

35. CORPORATE SOCIAL RESPONSIBILITY (CSR, COMPOSITION OF CSR COMMITTEE AND
CONTENTS OF CSR POLICY)

The company has attracted the provisions of Corporate Social Responsibility u/s 135 of Companies Act,
and accordingly has formed the CSR committee to oversee the CSR activities, adopted the CSR policy may
be accessed on the Company's website at: www.jeevanscientific.com. The Corporate Social Responsibility
Report is enclosed asAnnexure V.

In terms of Section 135 of the Companies Act, 2013 read with Companies (Corporate Social Responsibility
Policy) Rules, 2014 as amended (“CSR Rules”) and in accordance with the CSR Policy, during the financial
year 2024-2025, your Company has spent Rs. 5,50,500/- while the total obligation is Rs. 5,50,368/-
(representing 2 % of the average net profit for the past the three financial years, being FY 21-22, FY 2022¬
23 and FY2023-24). Company has spent CSRfunds on health CareActivities.

36. SECRETARIAL STANDARDS:

The Company has devised proper systems to ensure compliance with the provisions of all applicable
Secretarial Standards issued by the Institute of Company Secretaries of India and such systems are
adequate and operating effectively. During the year under review, the Company was in compliance with the
Secretarial Standards (SS) i.e., SS-1 and sS- 2, relating to “Meetings of the Board of Directors” and
“General Meetings”, respectively.

37. INSURANCE:

The properties and assets of your Company are adequately insured.

38. PARTICULARS OF LOANS, GUARANTEES OR INVESTMENTS:

The particulars of loans, guarantees or investments provided under Section 186 of the Companies Act,
2013 are as mentioned below:

39. INTERNAL FINANCIAL CONTROL SYSTEMS:

Your Company has well laid out policies on financial reporting, asset management, adherence to
Management policies and also on promoting compliance of ethical and well-defined standards. The
Company follows an exhaustive budgetary control and standard costing system. Moreover, the
management team regularly meets to monitor goals and results and scrutinizes reasons for deviations in
order to take necessary corrective steps. The Audit Committee which meets at regular intervals also
reviews the internal control systems with the Management and the internal auditors.

The Company laid down internal financial controls and that such internal financial controls are adequate
and were operating effectively.

40. RELATEDPARTYTRANSACTIONS:

All related party transactions that were entered into during the financial year were on arm's length basis and
in the ordinary course of business. The Form AOC-2 pursuant to Section 134(3)(h) of the Companies Act,
2013 read with Rule 8(2) of the Companies (Accounts) Rules, 2014 is annexed herewith asAnnexure-VI to
this report.

41. POLICYON DIRECTOR’S APPOINTMENT AND REMUNERATION:

In adherence to the provisions of Section 134(3)(e) and 178(1) & (3) of the CompaniesAct, 2013, the Board
of Directors upon recommendation of the Nomination and Remuneration Committee approved a policy on
Director's appointment and remuneration, including, criteria for determining qualifications, positive

attributes, independence of a Director and other matters. The said Policy extract is covered in Corporate
Governance Report which forms part of this Report and is also uploaded on the Company's website at
www.jeevanscientific.com.

42. TRANSFER OF UN-CLAIMED DIVIDEND TO INVESTOR EDUCATIONAND PROTECTION:

Pursuant to the provisions of Section 124 of the Companies Act 2013, Investor Education and Protection
Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016 (“IEPF Rules”) read with the relevant
circulars and amendments thereto, the amount of dividend remaining unpaid or unclaimed for a period of
seven years from the due date is required to be transferred to the Investor Education and Protection Fund
(“IEPF”), constituted by the Central Government

During the Year, no amount of dividend was unpaid or unclaimed fora period of seven years and therefore
no amount is required to be transferred to Investor Education and Provident Fund under the Section 125(1)
and Section 125(2)oftheAct.

43. SHARES TRANSFERRED TO INVESTOR EDUCATION AND PROTECTION FUND:

No shares were transferred to the Investor Education and Protection Fund during the year under review.

44. DETAILS OF NODAL OFFICER:

The Company has designated Mr. Krishna Sainadh Kodati as a Nodal Officer for the purpose of IEPF.

45. DETAILSOFUTILIZATIONOFFUNDS:

During the year under review, the Company has not raised any funds through Private Placement,
Preferential Allotment or Qualified Institutions Placement as specified under Regulation 32(7A) of the
Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations,
2015

46. STATEMENT SHOWING THE NAMES OF THE TOP TEN EMPLOYEES IN TERMS OF
REMUNERATION DRAWN AND THE NAME OF EVERY EMPLOYEE AS PER RULE 5(2) & (3) OF THE
COMPANIES (APPOINTMENT & REMUNERATION) RULES, 2014:

A table containing the particulars in accordance with the provisions of Section 197(12) of the Act, read with
Rule 5(2) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 is
appended as Annexure VII (a) to this Report.

Astatement showing the names of the top ten employees in terms of remuneration drawn and the name of
every employee is annexed to thisAnnual report as Annexure VII (b).

During the year, NONE of the employees (excluding Executive Directors) is drawing a remuneration of
Rs.1,02,00,000/- and above per annum or Rs.8,50,000/- and above in aggregate per month, the limits
specified under the Section 197(12) of the Companies Act,2013 read with Rules 5(2) and 5(3) of the
Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014.

47. RATIO OF REMUNERATION TO EACH DIRECTOR:

Under section 197(12) of the Companies Act, 2013, and Rule 5(1) (2) & (3) of the Companies (Appointment
& Remuneration) Rules, 2014, the ratio of remuneration to median employees is as mentioned in
Annexure-VII(a).

48. NON-EXECUTIVE DIRECTORS’COMPENSATIONAND DISCLOSURES:

None of the Independent / Non-Executive Directors has any pecuniary relationship or transactions with the
Company which in the Judgement of the Board may affect the independence of the Directors except Mr.
Jeevan Krishna Kuchipudi (Non- Executive Director) who is holding 9,17,772 Equity Shares.

49. INDUSTRY BASED DISCLOSURES AS MANDATED BY THE RESPECTIVE LAWS GOVERNING THE
COMPANY:

The Company is not a NBFC, Housing Companies etc., and hence Industry based disclosures is not
required.

50. FAILURE TO IMPLEMENT CORPORATEACTIONS:

During the year under review, no corporate actions were done by the Company which were failed to be
implemented.

51. DETAILS OF APPLICATION MADE OR PROCEEDING PENDING UNDER INSOLVENCY AND
BANKRUPTCY CODE, 2016:

During the year under review, there were no applications made or proceedings pending in the name of the
Company under Insolvency and Bankruptcy Code, 2016.

52. DETAILS OF DIFFERENCE BETWEEN VALUATION AMOUNT ON ONE TIME SETTLEMENT AND
VALUATION WHILEAVAILING LOAN FROM BANKSAND FINANCIAL INSTITUTIONS:

During the year under review, there has been no one time settlement of loans taken from banks and
financial institutions.

53. POLICIES:

The SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 mandated the formulation
of certain policies for all listed companies. All the policies are posted on our website
www.jeevanscientific.com.

54. STATUTORYCOMPLIANCE:

The Company has complied with the required provisions relating to statutory compliance with regard to the
affairs of the Company in all respects.

55. CODE OF CONDUCT FORTHE PREVENTION OF INSIDERTRADING:

Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time
to time, the Company has formulated a Code of Conduct for Prevention of InsiderTrading (“InsiderTrading
Code”) and a Code of Practices and Procedures for fair disclosure of Unpublished Price Sensitive
Information (“UPSI”).

The Code of Practices and Procedures for fair disclosure of UPSI is posted on the website of the Company
at https://www.jeevanscientific.com.

56. MD / CEO & CFO CERTIFICATION:

As required Regulation 17(8) read with Schedule II of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015, the MD / CEO & CFO certification is attached with the annual report as
AnnexureVIII.

57. PREVENTIONOFSEXUALHARASSMENTATWORKPLACE:

The Company has adopted a policy on Prevention of Sexual Harassment at Workplace which aims at
prevention of harassment of employees and lays down the guidelines for identification, reporting and
prevention of undesired behaviour.An Internal Complaints Committee (“ICC”) has been set up by the senior
management (with women employees constituting the majority). The ICC is responsible for redressal of
complaints against sexual harassment and follows the guidelines provided in the Policy.

During the financial year ended March 31,2025, no complaints pertaining to sexual harassment have been
received.

58. MATERNITYBENEFIT PROVIDED BYTHE COMPANYUNDER MATERNITY BENEFITACT1961

The Company declares that it has duly complied with the provisions of the Maternity Benefit Act, 1961. All
eligible women employees have been extended the statutory benefits prescribed under the Act, including
paid maternity leave, continuity of salary and service during the leave period, and post-maternity support
such as nursing breaks and flexible return-to-work options, as applicable. The Company remains
committed to fostering an inclusive and supportive work environment that upholds the rights and welfare of
its women employees in accordance with applicable laws.

59. EVENT BASED DISCLOSURES

During the year under review, the Company has not taken up any of the following activities:

a. Issueofsweatequityshare: NA

b. Disclosure on purchase by Company or giving of loans by it for purchase of its shares: NA

c. Buy backshares: NA

d. PreferentialAllotmentofShares: NA

e. Issue of equity shares with differential rights as to dividend, voting: NA

60. APPRECIATION & ACKNOWLEDGEMENT:

Your directors place on record their appreciation for the overwhelming co-operation and assistance
received from the investors, customers, business associates, bankers, vendors, as well as regulatory and
governmental authorities. Your directors also thank the employees at all levels, who through their
dedication, co-operation, support and smart work have enabled the Company to sustain its operations and
is determined to poise a rapid and remarkable growth in the years to come.

Your directors also wish to place on record their appreciation of all stakeholders including business
constituents, banks and other “financial institutions and shareholders of the Company SEBI, BSE, NSDL,
CDSL, Company's Bankers, etc. for their continued support for the growth of the Company.

For and on behalf of the Board of
Jeevan Scientific Technology Limited

Sd/-

K. Krishna Kishore

Place: Hyderabad Managing Director

Date: 14.08.2025 (DIN: 00876539)